Verwijs Marinus 4
4 · Aerovate Therapeutics, Inc. · Filed Nov 3, 2023
Insider Transaction Report
Form 4
Verwijs Marinus
Senior Vice President, CMC
Transactions
- Sale
Common Stock
2023-11-01$10.46/sh−970$10,149→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022.
- [F2]Includes 970 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.96 to $10.78, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.